New York State Common Retirement Fund Has $13.30 Million Stock Holdings in Azenta, Inc. (NASDAQ:AZTA)

New York State Common Retirement Fund lifted its position in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 41.0% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 265,983 shares of the company's stock after acquiring an additional 77,409 shares during the period. New York State Common Retirement Fund owned 0.58% of Azenta worth $13,299,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. Farther Finance Advisors LLC raised its stake in Azenta by 20.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company's stock valued at $74,000 after acquiring an additional 256 shares in the last quarter. QRG Capital Management Inc. increased its holdings in shares of Azenta by 6.6% during the third quarter. QRG Capital Management Inc. now owns 6,156 shares of the company's stock valued at $298,000 after purchasing an additional 383 shares during the period. Ballentine Partners LLC raised its stake in shares of Azenta by 2.0% during the fourth quarter. Ballentine Partners LLC now owns 20,340 shares of the company's stock valued at $1,017,000 after purchasing an additional 404 shares in the last quarter. Glenmede Trust Co. NA lifted its holdings in Azenta by 6.3% in the third quarter. Glenmede Trust Co. NA now owns 11,379 shares of the company's stock worth $551,000 after purchasing an additional 679 shares during the period. Finally, KBC Group NV grew its position in Azenta by 48.5% in the 4th quarter. KBC Group NV now owns 2,137 shares of the company's stock valued at $107,000 after buying an additional 698 shares in the last quarter. Institutional investors and hedge funds own 99.08% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. Needham & Company LLC boosted their price target on shares of Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a research report on Thursday, February 6th. Stephens reissued an "overweight" rating and set a $60.00 target price on shares of Azenta in a report on Thursday, January 2nd. Finally, Evercore ISI increased their price target on Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a research note on Thursday, February 6th.

Azenta Stock Performance

Shares of NASDAQ:AZTA traded down $4.10 during trading hours on Thursday, hitting $42.94. 1,027,581 shares of the company's stock traded hands, compared to its average volume of 509,971. The company's fifty day simple moving average is $50.43 and its two-hundred day simple moving average is $47.86. The company has a market cap of $1.96 billion, a price-to-earnings ratio of -14.41 and a beta of 1.47. Azenta, Inc. has a 52 week low of $38.82 and a 52 week high of $67.77.

Azenta (NASDAQ:AZTA - Get Free Report) last issued its earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share for the quarter, topping analysts' consensus estimates of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. On average, analysts anticipate that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.